The largest database of trusted experimental protocols

7 protocols using huvecs

1

Microfluidic Endothelial Cell Inflammation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to cell seeding, the surface of the microfluidic device was coated using 100 μg/ml human fibronectin (Sigma Aldrich, Israel) in PBS. Human umbilical vein endothelial cells (HUVECs), (Lonza, Israel) were used in all assays. HUVECs were cultured in T75/T150 flasks with ECM media supplemented with FBS, Endothelial Cell Growth Supplement, penicillin/streptomycin solution (ScienCell, Switzerland). HUVECs were trypsinized using trypsin B (Biological Industries, Israel), and 106 cells were seeded in each microfluidic channel. The cells were then incubated at 37°C and 5% CO2 with standard media for 2 hr to enable a stable cell adhesion.
Inflammation was induced by activating the HUVECs using 0.1 μg/ml TNF‐α (R&D Systems, MN) in a serum free media, which resulted in E‐selectin and ICAM‐1 over‐expression. The activation was induced under static conditions at 37°C and 5% CO2 over different durations (0.5–6 hr). Then the microfluidic channels were washed twice with PBS. Cells were then fixed using 4% paraformaldehyde (Sigma Aldrich, Israel) for 10 min at room temperature, washed three times and stored at 4°C.
+ Open protocol
+ Expand
2

Endothelial Cell Culture and Bacterial Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs) (PromoCell GmbH, Heidelberg, Germany) were used to test the effect of the bacteria on vascular properties. After thawing, the frozen HUVECs were expanded in low-serum endothelial cell growth medium (PromoCell) at 37°C with 5% CO2 in a humidifying incubator and used at passages p3 to p6 (30 (link), 44 (link)). Cells were grown to 80 to 90% confluence before being transferred to transparent polyethylene terephthalate (PET) Transwell supports (0.4 μm pore size, Greiner Bio-One, Austria), to a plastic well plate (Corning), to a glass-bottom well plate (Cellvis, Mountain View, CA), and to the insert chip (30 (link)). Before seeding, the uncoated substrates were treated with entactin-collagen IV-laminin (ECL) cell attachment matrix (Merck) diluted in Dulbecco’s modified Eagle’s medium (DMEM) (10 μg/cm2) for 1 h in the incubator. Then, the HUVECs, harvested with trypsin/EDTA solution (Biological Industries), were seeded inside the culture platforms at a density of 250,000 cells/cm2 and grown for 48 h. Then, bacteria were added and their effect on cell behavior was tested after 1 h, 4 h, and 24 h.
+ Open protocol
+ Expand
3

Culturing Human and Mouse Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human vascular endothelial cells (HUVECs) and L929 mouse skin fibroblasts were purchased from the Chinese Academy of Sciences (Shanghai, China) and cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% FBS (Biological Industries, USA) and 1% penicillin–streptomycin (Thermo Fisher Scientific, USA). Cells were incubated at 37 °C with 5% CO2.
+ Open protocol
+ Expand
4

Culturing Human Umbilical Vein Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human umbilical vein endothelial cells (HUVECs) were obtained from the Food Industry Research and Development Institute (Hsinchu, Taiwan). HUVECs were cultured with M199 medium containing 10% fetal bovine serum (FBS, Biological Industries, Boca Raton, FL, USA) on 1% gelatin-coated (Sigma-Aldrich, St. Louis, MO, USA) plates. Meanwhile, 20 μg/mL endothelial cell growth supplement (ECGS, Merck Millipore, Massachusetts, USA), 50 μg/mL heparin (Sigma-Aldrich, St. Louis, MO, USA), and 1% penicillin/streptomycin (Gibco, New York, NY, USA) were added to the culture medium. The cells were cultured in an incubator at 37 °C, humidified, containing 95% air and 5% CO2. The cultured cells were harvested for the following experiments at passages 6 to 8.
+ Open protocol
+ Expand
5

Angiogenesis Assay of VEGF and LY83583 on HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Matrigel basement membrane matrix (Corning, Corning, New York; 356231) was diluted in endothelial cell growth basal medium‐2 (Lonza, Basel, Switzerland; CC‐3156) and coated onto 96‐well plate at 37°C overnight. Then, 1 × 104 green fluorescent protein (GFP)‐tagged human umbilical vein endothelial cells (HUVECs; Essen BioScience, Ann Arbor, Michigan; 4453) in 50 μL serum‐free EBM‐2 media was seeded per well 1 hour prior to treatment. Cells were incubated for 6 hours in 100 ng/mL vascular endothelial growth factor (VEGF; PromoCell, Heidelberg Germany; C‐64420), 10 μM LY83583 soluble guanylate cyclase inhibitor (CAS 91300‐60‐6), and conditioned media from AMSC with or without Brachyury transfection; fixed with 4% paraformaldehyde; and imaged on a Leica DMI6000 B microscope (Leica, Wetzlar, Germany). Images were exported and analyzed using AngioTool.35 Proteome profiling was performed using the human angiogenesis array kit (R&D, Minneapolis, Minnesota; ARY007) and analyzed using the Quick Spots tool from HLImage++ software (Western Vision, Salt Lake City, Utah).
+ Open protocol
+ Expand
6

Maintaining and Passaging hiPSCs, CFs, and HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
hiPSCs were maintained in either mTeSR1 (Stemcell Technologies, Vancouver, BC, Canada) or AS103C (Ajinomoto, Tokyo, Japan).55 ,56 After reaching 70–80% confluency, hiPSCs were passaged as single cells using TrypLE Select Enzyme (1X) (Nacalai Tesque, Kyoto, Japan) and replated in mTeSR1 or AS103C medium with 10 μM Y-27632 (Fujifilm Wako Pure Chemical, Osaka, Japan). After two days, the medium was replaced with medium without Y-27632, and the cells were replaced daily until the next passage. Human neonatal ventricular CFs (Lonza) were maintained with MEMα (Thermo Fisher Scientific) medium including 2% sodium pyruvate (Sigma-Aldrich) and 5% FBS. HUVECs (Essen BioScience) were maintained using EGM2 (Lonza). After reaching 80%–90% confluency, these cells were passaged as single cells using 2.5 g/L Trypsin/1 mmol/L EDTA (Nacalai Tesque), counted using Vi-CELL (Beckman Coulter), subsequently plated in fibronectin-coated dishes.
+ Open protocol
+ Expand
7

Cardiac and Vascular Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human umbilical vein endothelial cells (HUVECs) and normal human
dermal fibroblasts (NHDF) were supplied by EssenBioScience and cultured in
Growth Medium and Complete Assay Medium (EssenBioScience) for the 2D network
formation assay.
For the 3D angiogenesis assay, HUVECs were purchased from Lonza
(C2519A), expanded and cultured in EGM-2 SingleQuots Kit media (Lonza). The cell
medium was changed every 3 days. HUVECs below passage 6 were used for all the in
vitro experiments.
Cardiomyocytes were differentiated from hiPSCs in chemically defined
conditions following established methods with slight modifications [35 (link), 36 (link)] and were used for producing cardiac engineered constructs
between day 14 and day 21 of differentiation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!